Patient was consented to hepatitis c treatment. Agrees to followup for repeat evaluation and tests as indicated for Hep C treatment. A consent form for HCV consent and compliance to treatment will be signed and scanned into chart. Furthermore, Hep A and Hep B vaccine status verified. Recommend visits at 4 week after starting treatment, at end of treatment, and 12 weeks after treatment. HCV Guidance recommends obtaining a quantitative HCV RNA level at baseline and at 12 weeks after completing therapy. It is also recommended to obtain an HCV RNA level 24 weeks after completing treatment in patients with cirrhosis (in addition to ultrasound every 6 months). https://www.hepatitisc.uw.edu/ used as a treatment reference.